[SCHEDULE 13G/A] Bicycle Therapeutics plc American SEC Filing
Armistice Capital, LLC and Steven Boyd report shared beneficial ownership of 359,703 American Depositary Shares of Bicycle Therapeutics plc, representing 4.99% of the class. Armistice Capital is the investment manager of the Master Fund, the direct holder of the shares, and under an Investment Management Agreement Armistice Capital exercises voting and investment power over those securities. Steven Boyd, as managing member of Armistice Capital, is reported with the same shared voting and dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing control.
Armistice Capital, LLC e Steven Boyd dichiarano la propriet脿 beneficiaria congiunta di 359.703 American Depositary Shares di Bicycle Therapeutics plc, pari al 4,99% della classe. Armistice Capital 猫 il gestore degli investimenti del Master Fund, detentore diretto delle azioni, e in virt霉 di un Investment Management Agreement esercita il potere di voto e di investimento su tali titoli. Steven Boyd, in qualit脿 di membro amministratore di Armistice Capital, risulta detenere lo stesso potere condiviso di voto e disposizione. Il deposito indica che i titoli sono stati acquisiti e sono detenuti nell'ordinario svolgimento dell'attivit脿 e non allo scopo di assumere il controllo.
Armistice Capital, LLC y Steven Boyd informan la propiedad beneficiaria compartida de 359.703 American Depositary Shares de Bicycle Therapeutics plc, que representan el 4,99% de la clase. Armistice Capital es el gestor de inversiones del Master Fund, titular directo de las acciones, y en virtud de un Investment Management Agreement ejerce el poder de voto y de inversi贸n sobre esos valores. Steven Boyd, como socio gestor de Armistice Capital, figura con el mismo poder compartido de voto y disposici贸n. La presentaci贸n indica que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar el control.
Armistice Capital, LLC鞕� 鞀ろ嫲敫� 氤挫澊霌滊姅 Bicycle Therapeutics plc鞚� 氤错喌欤检棎 頃措嫻頃橂姅 359,703臧滌潣 American Depositary Shares毳� 瓿惦彊鞙茧 鞁れ 靻岇湢頃橁碃 鞛堨潓鞚� 氤搓碃頃橂┌, 鞚措姅 頃措嫻 韥措灅鞀れ潣 4.99%鞐� 頃措嫻頃╇媹雼�. Armistice Capital鞚� 頃措嫻 欤检嫕鞚� 歆侅爲 氤挫湢頃� Master Fund鞚� 韴瀽 鞖挫毄靷澊氅�, Investment Management Agreement鞐� 霐半澕 頃措嫻 歃濌秾鞐� 雽�頃� 鞚橁舶甓� 氚� 韴瀽 甓岉暅鞚� 頄夓偓頃╇媹雼�. 鞀ろ嫲敫� 氤挫澊霌滊姅 Armistice Capital鞚� 甏�毽� 氅る矂搿滌劀 霃欖澕頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳 甓岉暅鞚� 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅╇媹雼�. 鞝滌稖靹滊電� 歃濌秾鞚� 韱奠儊鞝侅澑 鞐呺 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 歆�氚瓣秾 氤�瓴届潉 氇╈爜鞙茧 頃橃 鞎婌晿雼り碃 氇呾嫓頃╇媹雼�.
Armistice Capital, LLC et Steven Boyd d茅clarent la propri茅t茅 b茅n茅ficiaire conjointe de 359 703 American Depositary Shares de Bicycle Therapeutics plc, repr茅sentant 4,99 % de la cat茅gorie. Armistice Capital est le gestionnaire des investissements du Master Fund, d茅tenteur direct des actions, et, en vertu d鈥檜n Investment Management Agreement, exerce le pouvoir de vote et d鈥檌nvestissement sur ces titres. Steven Boyd, en tant que membre g茅rant d鈥橝rmistice Capital, est indiqu茅 comme disposant des m锚mes pouvoirs partag茅s de vote et de disposition. Le d茅p么t indique que les titres ont 茅t茅 acquis et sont d茅tenus dans le cours normal des affaires et non dans le but de changer le contr么le.
Armistice Capital, LLC und Steven Boyd melden gemeinsam die wirtschaftliche Eigent眉merschaft an 359.703 American Depositary Shares von Bicycle Therapeutics plc, was 4,99% der Klasse entspricht. Armistice Capital ist der Investmentmanager des Master Fund, der unmittelbare Inhaber der Aktien, und 眉bt gem盲脽 eines Investment Management Agreement Stimm- und Investitionsbefugnisse 眉ber diese Wertpapiere aus. Steven Boyd wird als gesch盲ftsf眉hrendes Mitglied von Armistice Capital mit denselben gemeinsamen Stimm- und Verf眉gungsbefugnissen angegeben. Die Meldung besagt, dass die Wertpapiere im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten werden und nicht zum Zweck der 脺bernahme von Kontrolle.
- Clear disclosure of beneficial ownership with exact share count (359,703) and percentage (4.99%)
- Certification of ordinary-course investment intent stating shares are not held to change control
- Joint filing coordination clarifies responsibility and relationship among Reporting Persons
- None.
Insights
TL;DR A passive sub-5% disclosure showing an investment manager and its managing member with shared voting power over 4.99% of BCYC ADSs.
This Schedule 13G/A reports that Armistice Capital, as investment manager to the Master Fund, and Steven Boyd as its managing member, share voting and dispositive power over 359,703 ADSs representing 4.99% of Bicycle Therapeutics plc's ADS class. The filing emphasizes ordinary-course investment intent and expressly disclaims an intent to influence control of the issuer. For investors, this is a routine beneficial-ownership disclosure reflecting a modest stake by an activist-capable manager but filed under passive ownership rules.
TL;DR Formal joint Schedule 13G/A clarifies roles and confirms shared control signals without alleging change-of-control intent.
The joint filing clarifies that the Master Fund holds the ADSs while Armistice Capital exercises voting and investment power under an Investment Management Agreement and that Mr. Boyd may be deemed to beneficially own the holdings by virtue of his management role. The certification states the shares are held in the ordinary course and not for control purposes. The joint filing statement documents allocation of filing responsibility among the Reporting Persons.
Armistice Capital, LLC e Steven Boyd dichiarano la propriet脿 beneficiaria congiunta di 359.703 American Depositary Shares di Bicycle Therapeutics plc, pari al 4,99% della classe. Armistice Capital 猫 il gestore degli investimenti del Master Fund, detentore diretto delle azioni, e in virt霉 di un Investment Management Agreement esercita il potere di voto e di investimento su tali titoli. Steven Boyd, in qualit脿 di membro amministratore di Armistice Capital, risulta detenere lo stesso potere condiviso di voto e disposizione. Il deposito indica che i titoli sono stati acquisiti e sono detenuti nell'ordinario svolgimento dell'attivit脿 e non allo scopo di assumere il controllo.
Armistice Capital, LLC y Steven Boyd informan la propiedad beneficiaria compartida de 359.703 American Depositary Shares de Bicycle Therapeutics plc, que representan el 4,99% de la clase. Armistice Capital es el gestor de inversiones del Master Fund, titular directo de las acciones, y en virtud de un Investment Management Agreement ejerce el poder de voto y de inversi贸n sobre esos valores. Steven Boyd, como socio gestor de Armistice Capital, figura con el mismo poder compartido de voto y disposici贸n. La presentaci贸n indica que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar el control.
Armistice Capital, LLC鞕� 鞀ろ嫲敫� 氤挫澊霌滊姅 Bicycle Therapeutics plc鞚� 氤错喌欤检棎 頃措嫻頃橂姅 359,703臧滌潣 American Depositary Shares毳� 瓿惦彊鞙茧 鞁れ 靻岇湢頃橁碃 鞛堨潓鞚� 氤搓碃頃橂┌, 鞚措姅 頃措嫻 韥措灅鞀れ潣 4.99%鞐� 頃措嫻頃╇媹雼�. Armistice Capital鞚� 頃措嫻 欤检嫕鞚� 歆侅爲 氤挫湢頃� Master Fund鞚� 韴瀽 鞖挫毄靷澊氅�, Investment Management Agreement鞐� 霐半澕 頃措嫻 歃濌秾鞐� 雽�頃� 鞚橁舶甓� 氚� 韴瀽 甓岉暅鞚� 頄夓偓頃╇媹雼�. 鞀ろ嫲敫� 氤挫澊霌滊姅 Armistice Capital鞚� 甏�毽� 氅る矂搿滌劀 霃欖澕頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳 甓岉暅鞚� 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅╇媹雼�. 鞝滌稖靹滊電� 歃濌秾鞚� 韱奠儊鞝侅澑 鞐呺 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 歆�氚瓣秾 氤�瓴届潉 氇╈爜鞙茧 頃橃 鞎婌晿雼り碃 氇呾嫓頃╇媹雼�.
Armistice Capital, LLC et Steven Boyd d茅clarent la propri茅t茅 b茅n茅ficiaire conjointe de 359 703 American Depositary Shares de Bicycle Therapeutics plc, repr茅sentant 4,99 % de la cat茅gorie. Armistice Capital est le gestionnaire des investissements du Master Fund, d茅tenteur direct des actions, et, en vertu d鈥檜n Investment Management Agreement, exerce le pouvoir de vote et d鈥檌nvestissement sur ces titres. Steven Boyd, en tant que membre g茅rant d鈥橝rmistice Capital, est indiqu茅 comme disposant des m锚mes pouvoirs partag茅s de vote et de disposition. Le d茅p么t indique que les titres ont 茅t茅 acquis et sont d茅tenus dans le cours normal des affaires et non dans le but de changer le contr么le.
Armistice Capital, LLC und Steven Boyd melden gemeinsam die wirtschaftliche Eigent眉merschaft an 359.703 American Depositary Shares von Bicycle Therapeutics plc, was 4,99% der Klasse entspricht. Armistice Capital ist der Investmentmanager des Master Fund, der unmittelbare Inhaber der Aktien, und 眉bt gem盲脽 eines Investment Management Agreement Stimm- und Investitionsbefugnisse 眉ber diese Wertpapiere aus. Steven Boyd wird als gesch盲ftsf眉hrendes Mitglied von Armistice Capital mit denselben gemeinsamen Stimm- und Verf眉gungsbefugnissen angegeben. Die Meldung besagt, dass die Wertpapiere im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten werden und nicht zum Zweck der 脺bernahme von Kontrolle.
FAQ
How many Bicycle Therapeutics plc ADSs does Armistice Capital report owning?
Does the Schedule 13G/A state Armistice Capital intends to influence control of BCYC?
Who is the direct holder of the reported shares?
What voting and dispositive powers are reported by the filing?
When was this Schedule 13G/A signed and by whom?
